94 related articles for article (PubMed ID: 3006185)
1. [Immunologic markers of the risk of cytomegalovirus infection among immunosuppressed patients].
Tardy JC; Bosshard S; Aymard M
Rev Epidemiol Sante Publique; 1985; 33(4-5):297-303. PubMed ID: 3006185
[TBL] [Abstract][Full Text] [Related]
2. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
3. Overt cytomegalovirus (CMV) infection following renal transplantation--usefulness of CFA, NIA, PENA antibodies as markers in serological diagnosis and evaluation of risk factors influencing the manifestations of CMV infection.
Nakamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):631-53. PubMed ID: 6306871
[TBL] [Abstract][Full Text] [Related]
4. [Serologic diagnosis of cytomegalic inclusion disease using the Elisa technic in kidney transplant patients].
Dennin RH; Herhan J; Schulz E; Sack K
Dtsch Med Wochenschr; 1984 Feb; 109(6):214-6. PubMed ID: 6321127
[TBL] [Abstract][Full Text] [Related]
5. [Detection of cytomegalovirus antibody levels in renal transplant patients by complement fixation and ELISA tests].
Saify SJ; Ustaçelebi S; Haberal M
Mikrobiyol Bul; 1986 Oct; 20(4):256-65. PubMed ID: 2821363
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
Jankowski M; Styczyński P
Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
[TBL] [Abstract][Full Text] [Related]
7. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus antibodies in renal transplant recipients.
Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
[TBL] [Abstract][Full Text] [Related]
9. [Specific IgM of cytomegaloviruses and primary infection in kidney transplant patients].
Devillechabrolle A; Nguyen TT; Luciani J; Frantz P; Huraux JM
Pathol Biol (Paris); 1987 Oct; 35(8):1123-6. PubMed ID: 2825100
[TBL] [Abstract][Full Text] [Related]
10. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection.
Basson J; Tardy JC; Aymard M
J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984
[TBL] [Abstract][Full Text] [Related]
11. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
13. [Serologic diagnosis of primary cytomegalovirus infections in patients following kidney transplantation using the indirect immunofluorescence technic and the complement-fixation test].
Eichler C; Kaden J; Adamczyk G; Gärtner L
Z Urol Nephrol; 1985 Aug; 78(8):447-50. PubMed ID: 3002072
[TBL] [Abstract][Full Text] [Related]
14. The respective advantages of complement fixation and ELISA for routine diagnosis of cytomegalovirus infection.
Pozzetto B; Gaudin OG
Biomedicine; 1981 Nov; 35(6):187-90. PubMed ID: 6279196
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
16. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
[TBL] [Abstract][Full Text] [Related]
17. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
[TBL] [Abstract][Full Text] [Related]
18. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
Chehimi J; Peppard J; Emanuel D
Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
[TBL] [Abstract][Full Text] [Related]
19. [Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
Freymuth F; Petitjean J; Eugene-Ruelland G; Daon F; Galateau F
Pathol Biol (Paris); 1993 Oct; 41(8):724-30. PubMed ID: 8290319
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.
Dreikorn K; Doerr HW; Geursen RG
Scand J Urol Nephrol Suppl; 1985; 92():15-21. PubMed ID: 3008312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
